Bladder cancer is the most common malignant tumor in the urinary system. The standard treatment of muscle-invasive bladder cancer (MIBC) is the radical cystectomy combined with pelvic lymphadenectomy. In recent years, radiotherapy has played an important role in the MIBC bladder-preserving treatment model. This article will review the advances in the application of radiotherapy for bladder preservation in MIBC, and introduce the application progress of radiotherapy in trimodality therapy of adjuvant radiotherapy and chemotherapy after transurethral resection of bladder tumors, radical radiotherapy, preoperative radiotherapy, radiotherapy combined with immunotherapy, the development and challenges of radiotherapy technology, and radiotherapy-related adverse reactions. The aim of this article is to provide a reference for further exploration of a more scientific and effective comprehensive treatment mode for bladder preservation.
The teaching of Clinical Pharmacology plays a very important role in medical education. In this article, we introduce our exploration and practice in Clinical Pharmacology course in West China Hospital of Sichuan University, which combines Good Clinical Practice with teaching methods such as problem-based learning and case-based learning. Furthermore, we analyze the actual effects in optimizing teaching content, renewing teaching mode, and improving teachers’ teaching ability, etc. We hope this article could provide new ideas for the teaching reform of undergraduate Clinical Pharmacology course.
Bladder cancer is one of the most common cancers of the urinary system. Baesd on the involvement of the blandder muscle or not, bladder cancer can be generally classified into muscule-invasive bladder cancer (MIBC) and non-MIBC. Cisplatin-based neoadjuvant chemotherapy followed by radical cystectomy is the standard treament recommended by current guidelines for MIBC. Based on the good efficacy of immunocheckpoint inhibitors in advanced bladder cancer. More and more studies have explored the safety and efficacy of immunotherapy in MIBC neoadjuvant therapy, and analyzed biomarkers to explore the benefit groups. This article reviews the latest progress of various neoadjuvant immunomonotherapy in MIBC, and prospect the future direction of development.
【摘要】 目的 调强放射治疗（IMRT）能较好的保护危及器官并给予肿瘤足够的致死剂量，基于多叶准直器（MLC）分步照射的IMRT技术对复杂病例需要更多子野。研究对直肠癌术后放射治疗使用不同子野数目的IMRT计划进行比对，选择合理的子野数。 方法 选取2010年4-8月入院的直肠癌术后患者10例，保持射野入射角度及优化目标参数相同，仅改变MLC子野数目，设计不同IMRT对每一患者治疗计划的靶区适形指数（CI）、均匀性指数、最大剂量、最小剂量、平均剂量，危及器官关注体积的受照剂量，机器跳数及治疗时间进行分析。 结果 所有治疗计划中靶区及危及器官的剂量学评估指标无统计学意义（Pgt;0.05），只有亚临床计划靶区（PTV）CI在15个子野的方案中（0.74±0.06）明显差于25个子野方案（0.82±0.03）、40个子野方案（0.81±0.06）及60个子野方案（0.84±0.03），有统计学意义（Plt;0.05）；治疗机器跳数（MU）随子野数目增多明显增大，15、20、40及60个子野方案所需MU分别为（458±56）、（559±62）、（614±74）、（622±82），有统计学意义（Plt;0.05），但40个子野方案与60个子野方案间无统计学意义。治疗时间明显随子野数增加而增大。 结论 直肠癌术后IMRT计划使用25个子野能满足临床剂量要求，同时能有效降低治疗时间，可作为临床应用参考值。【Abstract】 Objective The intensity modulated radiotherapy (IMRT) can deliver tumor enough doses and protect risk organs as much as possible at the same time. The MLC-based step and shoot IMRT(sIMRT) plan needs much more segment member to meet clinical aims. In this study, several sIMRT plans using different segment number for postoperative rectal cancer were compared to find out the most reasonable segment number setting. Methods Ten patients with rectal carcinoma underwent postoperative adjuvant radiotherapy for rectal cancer from April to August 2010 were selected. For each patient, the angle of field, the prescription expected and the physical parameters optimized were kept the same, while only the number of segments was changed in sIMRT plans. The dose volume histogram-based parameters [conformity index (CI) and homogeneous index (HI)] and other parameters concerned were compared and analyzed. Results The indexes of dosimetry associated with the targets and risk organs showed no significant statistical difference among the 4 sIMRT plans with different segment numbers. The index CI of PTV in the sIMRT plan with 15 segments (CI 0.74±0.06) was less than that in the sIMRT plan with 25 segments (CI 0.82±0.03), the sIMRT plan with 40 segments plan (CI 0.81±0.06), and the sIMRT plan with 60 segments (CI 0.84±0.03) (Plt;0.05). There were significant differences in MU among the sIMRT plans with 15 segments (average MU: 458±56) , with 25 segments (average MU: 559±62 ), and with 40 segments (average MU: 614±74)or with the 60 segments (average MU: 622±82 (Plt;0.05). The more segments meant more MU and more irradiation time. Conclusion The sIMRT plan for patients of rectal cancer to receive postoperative adjuvant radiotherapy may require at least 25 segments to balance the accepted dose results and efficient delivering.
Objective To evaluate the efficacy and side effect of non-conventional fractionated radiotherapy for head and neck cancer.Methods Trials were identified by searching CENTRAL, MEDLINE, EMBASE, Chinese Biological Medicine Database (CBMdisc) and Chinese VIP Database. We handresearched the data from 10 kinds of important Chinese journals. Two reviewers assessed and extracted the studies. The following primary outcomes were assessed: complete relief (CR), overall survival (OS), acute side effect and late side effect. Results Twenty-three trials involving 8 411 patients were included. Thirteen trials were of good quality, and the rest were of poor quality. Meta-analysis of these trials showed that: (1) non-conventional fractionated radiotherapy vs conventional fractionated radiotherapy: ① Only S-HART and CAIR resulted in higher CR, RR=1.21 (95%CI 1.02 to 1.44), 3.31 (95%CI 1.16 to 9.42), respectively; ② Only HRT could improve 2-year OS (RR=1.32, 95%CI 1.13 to 1.54), but this difference wasn’t found in 5-year follow up; ③ Most of the non-conventional fractionated radiotherapy could increase acute side effects, but not the late ones; (2) non-conventional fractionated radiotherapy combined with concurrent chemotherapy vs non-conventional fractionated radiotherapy: ① Only C-HRT resulted in higher CR (RR=1.58, 95%CI 1.18 to 2.11); ② Higher 2-year OS could be gained when combined with chemotherapy (RR=1.35, 95%CI 1.18 to 1.54), and only C-HRT resulted in higher 5-year OS (RR=1.57, 95%CI 1.19 to 2.07). ③ Acute and late side effects of radiotherapy would not increase when combined with chemotherapy. Conclusion It can not be concluded that non-conventional fractionated radiotherapy can improve the CR and OS of head and neck cancer, for a small number of patients, but it will get effect when combined with concurrent chemotherapy, and would not increase acute or late side effects. The effects of HRT and C-HRT should be cared specially.
ObjectiveTo compare the static intensity-modulated radiation therapy (IMRT) plans using different beams sets and segments number, and find the better static IMRT plan sets on beams and segments in gastric surgical adjuvant radiotherapy.MethodsFifteen patients who underwent adjuvant radiotherapy for gastric cancer between February 1st and August 30th, 2013 were chosen as subjects through random sampling. Based on the 5 beams static IMRT plans already used in clinical practice, four different static IMRT plans used diverse beams sets for each patient were designed in the same treatment planning system (Pinnacle 9.2). The beams sets of static IMRT plans were as follows: 7 coplanar equal beams; 5 coplanar equal beams; 4 coplanar beams of 310, 20, 90 and 180°; 3 coplanar beams of 310, 65 and 180°. Sufficient segments 65 was set as the max segments number in order to compare the plans’ difference just resulting from beams. In the second step, the max segments number was changed from 65 to 45 and 25 to design two different static IMRT plans for the 4 coplanar beams static IMRT plans. The dosimetric parameters were compared for the planning target volume (PTV) and organs at risk (OARs). The monitor units and treatment times of the different static IMRT plans were also evaluated.ResultsWhen the max segments number was set to 65, the 4 coplanar beams static IMRT plans were a little better on PTV conformability than the 5 coplanar beams static IMRT plans used in clinical practice (0.74±0.04 vs. 0.73±0.05, P<0.01). Meanwhile, better OARs dose sparing especially for liver and kidneys were gained by the 4 coplanar beams static IMRT plans, for example, the percent volume gained 30 Gy for liver [(22.71±6.10)%vs. (24.03±6.84)%, P<0.01] and the percent volume gained 20 Gy for the right kidney [(14.97±6.72)%vs. (19.41±6.14)%, P<0.01]. The PTV conformability of the 4 coplanar beams static IMRT plans reduced as the max segments number became smaller (0.74±0.04vs. 0.73±0.04 vs. 0.71±0.04, P<0.05). However, they were still acceptable in clinical practice. And the better dose sparing for liver and kidneys were retained. The average reductions of 1.8 and 4.3 minutes on the irradiation time were get by the 4 coplanar beams static IMRT plans with the max segments number 45 and 25 compared to that with the max segments number 65 [(494.66±26.79)vs. (384.26±14.99) vs. (235.00±9.21) s, P<0.01]. And the raises of treatment efficiency were 22.3% and 52.4%, respectively (P<0.05).ConclusionsThe 4 coplanar beams static IMRT plans with fewer segments could ensure plan quality, and protect the OARs better in the meanwhile, especially for liver and kidneys. The treatment time is reduced as well. The 4 coplanar beams static IMRT plans could improve the treatment efficiency.